[1] Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature.1999;402: 656-660. [2] Han D,Huang W,Ma S,et al.Ghrelin improves functional survival of engrafted adipose-derived mesenchymal stem cells in ischemic heart through PI3K/Akt signaling pathway. Biomed Res Int.2015;2015: 858349. [3] Akamizu T, Takaya K, IrakoT, et al. Pharmacokinetics, safety, and endocrine and appetite effects of Ghrelin administration in young health subjects. Eur J Endocrinol. 2004;150:447-455. [4] Hosoda H, Kojima M, Matsuo H, et al. Purification and characterization of rat des-Gln14-Ghrelin, a second endogenous ligand for the growth secretagogue receptor. Biol Chem. 2000;275: 21995-22000. [5] Date Y, Kojima M, Hosoda H, et al. Ghrelin,a novel growth hormone-releasing acylated peptide,is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141: 4255-4261.[6] Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of Ghrelin and subtypes of its receptor,GHS-R,in humans. Clin Endocrinol Metab.2002;87: 2988.[7] Cowley MA, Smith RG, Diano S, et al. The distribution and mechanism of action of Ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 2003;37: 649-661.[8] Wang G, Lee HM. Ghrelin not just another stomach hormone. Regulatory Peptide. 2002;105:75-81.[9] Howard AD, Feighner SD, Cully DF,et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science.1996;273:974-977.[10] Nogueiras R, Tovar S, Mitchell SE, et al. Regulation of growth hormone secretagogue receptor gene expression in the arcuate nuclei of the rat by leptin and Ghrelin. Diabetes.2004; 53: 2552-2558. [11] Sakurazawa N, Mano-Otagiri A, Nemoto T,et al. Effects of intracerebroventricular Ghrelin on food intake and Fos expression in the arcuate nucleus of the thpothalamus in female rats vary with estrous cycle phase.Neurosci Lett. 2013;541:204-208.[12] Cone JJ, McCutcheon JE, Roitman MF. Ghrelin acts as an interface between physiological state and phasic dopamine signaling.J Neurosci.2014;34(14): 4905 -4913.[13] Cheung CK, Wu JC. Role of Ghrelin in the pathophysiology of gastrointestinal disease. Gut Liver.2013;7(5): 505-512. [14] 王燕,史海涛,秦斌, 等.Ghrelin对大鼠小肠转运的作用及对中枢和胃肠道c-Fos表达的影响[J]. 西安交通大学学报:医学版,2014, 35(5):611-617.[15] Bron R, Yin L, Russo D, et al. Expression of the Ghrelin receptor gene in neurons of the medulla oblongata of the rat. J Comp Neurol. 2013;521(12): 2680-2702.[16] 李丽,徐珞.Ghrelin对糖尿病大鼠摄食的影响[J],青岛大学医学院院报,2014, 50(1): 13-18.[17] Stark R,Reichen bach A,Lockie SH,et al.Acyl Ghrelin acts in the brain to control liver function and peripheral glucose homeostasis in male mice.Endocrinology.2015;156(3) : 858-868.[18] Gauna C, Kiewiet RM, Janssen JA, et al. Unacylated Ghrelin acts as apotent insulin secretagogue in glucose-stimulated conditions. Am J Physiol Endocrinol Metab.2007;293: E697-E704.[19] Barzon L, Pacenti M, Masi G, et al. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors. Oncology. 2005;68: 414-421.[20] Shi L, Bian X, Qu Z, et al.Peptide hormone Ghrelin enhances neuronal excitability by inhibition of Kv7/ KCNQ channels. Nature Communications.2013;4:1435.[21] Wang Q, Liu C, Uchida A, et al. Arcuate AgRP neurons mediate orexigenic and glucoregulatory actions of Ghrelin. Mol Metab.2013;3(1):64-72.[22] Stoyanova II. Ghrelin: a link between ageing, metabolism and neurodegenerative disorders. Neurobiology Disease. 2014; 72(Pt A):72-83.[23] Li E, Kim Y, Kim S, et al. Ghrelin stimulates proliferation, Migration and differentiation of neural progenitors from the Subventricular zone in the adult mice.Experimental Neurology. 2014;252:75-84.[24] Li E, Kim Y, Kim S et al. Ghrelin-induced hippocampal neurogenesis and enhancement of cognitive function are mediated independently of GH/IGF-1 axis: lessons from the spontaneous dwarf rats. Endocrine Journal.2013;60(9): 1065-1075. [25] Kadoglon NP,Fotiadis G,Lambadiari V,et al. Serum levels of novel adipokines in patients with acute ischemic stroke : potential contribution to diagnosis and prognosis. Peptides. 2014;57(7): 12-16. [26] Müller TD, Nogueiras R, Andermann ML,et al. Ghrelin. Molecular Metabolism.2015;4(6): 437-460.[27] Qi Y, Inoue K, Fu M, et al.Chronic overproduction of Ghrelin in the hypothalamus leads to temporal increase in food intake and body weight.Neuropeptides. 2015;50(4): 23-28.[28] Barazzoni R,Bosutti A,Stebel M,et al. Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. Am J Physiol Endocrinol Metab.2005;288(1):E228-E235.[29] Murphy KG, Bloom SR. Gut hormones and the regulation of energy homeostasis. Nature. 2006;444(12):854-859.[30] Lely AJ, Tschop M, Heiman ML. Biological, Physiological, PathophySiological, and Pharmacological Aspects of Ghrelin. Endocrine Review.2004;25(10):426-457.[31] Leite-Moreira AF, Soares JB. Adelino F. Physiological, Pathological and potential therapeutic roles of Ghrelin. Drug Discovery Today. 2007;12(4):276-288.[32] Thompson NM, Gill DA, Davies R, et al. Ghrelin and desoctanoyl Ghrelin promote adipogenesis directlyin vivoby a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology. 2004;145(1):234-242.[33] Kojima M, Kangawa K. Ghrelin: Structure and Function. Physiological Review.2005;85(2): 495-522.[34] Amini P, Cahill F, Wadden D, et al. Beneficial association of serum Ghrelin and peptide YY with bone mineral density in the Newfoundland population.BMC Endocrine Disorder.2013; 12(9): 35.[35] Kim SW, Her SJ, Park SJ. Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3- E1 cells.Bone.2005;3:359-369. [36] Dellhanty PJ, van der Eerden BC, van Leeuwe JP. Ghrelin and bone. Biofacts.2014;40(1): 41-48.[37] Liang Q H,Liu Y,Wu S S,et al. Ghrelin inhabits the apoptosis of MC3T3-E1 cells through ERK and AKT signaling pathway. Toxicol Appl Pharmacol.2013;272(3): 591 -597.[38] Bachrach L. Acquisition of optimal bone mass in childhood and adolescence. Trends Endocrinol Metab.2001;12(1): 22-28.[39] Biller B, Saxe V, Herzog D, et al. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. Clin Endocrinol Metab.1989;68(3): 548-549.[40] Delhanty PJ, van der Eerden BC, van der Velde M, et al. Ghrelin and unacylated Ghrelin stimulate human osteoblast growth via mitogenactivated protein kinase (MAPK)/ phosphoin-ositide 3-kinase (PI3K) pathways in the absence of GHS-R1a. Endocrinol. 2006;188(1):37-47.[41] Caminos JE, Gualillo O, Lago F, et al.The endogenous growth hormone secretagogue (Ghrelin) is synthesized and secreted by chondrocytes. Endocrinology. 2005;146(3): 1285 -1292.[42] Cocchi D, Maccarinelli G, Sibilia V. GH-releasing peptides and bone. Endocrinol Invest.2005;28 (8 Suppl):11-14. [43] schop M, Weyer C, Tataranni PA, et al. Circulating Ghrelin levels are decreased in human obesity. Diabetes.2001;50(4): 707-709.[44] Zhang W, Zhao L, Lin TR, et al. Inhibition of adipogenesis by Ghrelin. Mol Biol Cell. 2004;15(5):2484-2491.[45] Higuchi C, Myoui A, Hashimoto N, et al. Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix. Bone Miner Res.2002;17(10):1785-1794. [46] Shelton JG, Steelman LS, White ER, et al. Synergy between PI3K/Akt and Raf/MEK/ERK pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cells. Cell Cycle.2004;3(3): 372-379. [47] Kazama JJ. Osteoprotegerin and bone mineral metabolism in renal failure. Curr Opin Nephrol Hypertens.2004;13(4): 411-415.[48] Chua CC, Chua BH, Chen Z, et al. Dexamethasone induces caspase activation in murine osteoblastic MC3T3-E1 cells. Biochim Biophys Acta.2003;1642(1-2): 79-85.[49] Sang WK, Ok KC, Ju YJ, et al. Ghrelin Inhibits Early Osteogenic Differentiation of C3H10T1/2 Cells by Suppressing Runx2 Expression and Enhancing PPARg and C/EBPa Expression. Cellular Biochemistry.2009;106(4): 626-632. [50] 周华, 杨曦, 张雅鸥,等. Ghrelin抑制小鼠骨髓基质细胞成脂分化[J]. 基础医学与临床, 2007, 27(6): 886-890.[51] Kim MS, Yoon CY, Jang PG, et al. The mitogenic and anti-apoptotic actions of Ghrelin in 3T3-L1 adipocytes. Mol Endocrinol.2004;18(9): 2291-2301. [52] Nuttall ME, Gimble JM. Controlling the balance between Osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol.2004; 4(3): 290-294.[53] Pei L, Tontonoz P. Fat’s loss is bone’s gain. J Clin Invest. 2004;113(6): 805-806 |